Free Trial

Phathom Pharmaceuticals (PHAT) SEC Filings & 10K Form

Phathom Pharmaceuticals logo
$8.35 -0.19 (-2.22%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$8.40 +0.05 (+0.59%)
As of 08/1/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Phathom Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/24/2025
4:00 PM
Cook Anne Marie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2025
4:00 PM
Cook Anne Marie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
9:47 AM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
06/06/2025
12:29 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
06/05/2025
3:54 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:55 PM
Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:56 PM
FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:56 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:58 PM
COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:58 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:30 PM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/23/2025
3:06 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
4:17 PM
Breedlove Robert Charles (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:22 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
05/08/2025
4:27 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
6:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
6:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
1:30 PM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:03 PM
Phathom Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
3:05 PM
Phathom Pharmaceuticals (Filer)
Form DEFA14A
04/16/2025
4:37 PM
Phathom Pharmaceuticals (Issuer)
Schroeder Theodore R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2025
4:44 PM
Phathom Pharmaceuticals (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
4:29 PM
Basta Steven L (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2025
4:30 PM
Basta Steven L (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
4:08 PM
Phathom Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/01/2025
7:17 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:46 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:27 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:18 PM
Phathom Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:24 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:20 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:05 AM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:05 AM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
10:46 AM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
11/07/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:12 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
11/05/2024
2:32 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G
11/04/2024
10:20 AM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
08/22/2024
3:05 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13D/A
08/19/2024
4:12 PM
Phathom Pharmaceuticals (Filer)
Form 424B5
08/19/2024
4:13 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
5:05 AM
Phathom Pharmaceuticals (Subject)
Form FWP
08/08/2024
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PHAT) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners